|
This is the third of 10 messages we will send related to the PEBB Program’s annual open enrollment. The messages are numbered for easy tracking.
Do not forward this email directly to employees or make any significant content changes. Instead, copy and paste the message below and distribute to employees through your regular communication channels. You may modify payroll or benefits office information and other employer-specific content as needed to meet the needs of your employees.
Thank you in advance for your time and effort to share these messages. If you have comments or suggestions, contact us through HCA Support.
Please share the following message with employees around Wednesday, October 21.
New PEBB Program medical benefits for 2027
Below are some new benefits that will be available under Public Employees Benefits Board (PEBB) medical plans. All changes are effective January 1, 2027, unless otherwise noted. View the full list of changes in the Changes to PEBB benefits in 2027 announcement.
Birth doula benefit
Kaiser Permanente Northwest (KPNW)
KPNW-contracted doulas will be covered for up to four visits total during pregnancy and for up to 12 months after birth. Members also have doula coverage for delivery. Consumer-directed health plan (CDHP) members must first meet the deductible.
Kaiser Permanente Washington (KPWA)
Doulas from an established, licensed provider will be covered up to four visits total during pregnancy and for up to 12 months after birth. Members also have doula coverage for delivery. There is a $1,000 coverage limit per pregnancy. CDHP members must first meet the deductible.
Uniform Medical Plan (UMP)
Members may file claims for reimbursement of up to $1,000 per calendar year. Services must be provided in Washington state by a Washington Department of Health (DOH)-certified birth doula. CDHP members must first meet the deductible.
HIV prevention and treatment
Senate Bill 6183 requires coverage of all FDA-approved antiviral drugs for the prevention or treatment of HIV without prior authorization or step therapy. If there is a therapeutically equivalent, generic antiviral drug available, plans do not need to cover the brand-name version.
|